Remimazolam  in Pediatric Anesthesia and Sedation

AbstractPurpose of the ReviewThis review summarizes the updated literature on the use of remimazolam in children both as an anesthetic and a sedative agent for minor procedures. We herein present a brief overview of the pharmacokinetics and pharmacodynamics of remimazolam along with available evidence to support its use in children.Recent FindingsSince its FDA approval in 2020 for adults, remimazolam has been used in children, but the literature establishing its safety profile in children is sparse. In this article, we summarize published reports so that readers can make their own judgment on the current value of remimazolam in pediatric anesthesia and sedation.SummaryRemimazolam may offer advantages over propofol in a variety of clinical settings based on the available data, primarily from adult studies. Further studies are needed in infants and children to clearly establish its safety profile in this population.
Source: Current Anesthesiology Reports - Category: Anesthesiology Source Type: research